Phuong N. Huynh

Array ( [id] => 6134465 [patent_doc_number] => 20110008367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'ANTI-VEGF ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/847757 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9292 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008367.pdf [firstpage_image] =>[orig_patent_app_number] => 12847757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148751 [patent_doc_number] => 20110020346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/844616 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 53209 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020346.pdf [firstpage_image] =>[orig_patent_app_number] => 12844616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195544 [patent_doc_number] => 20110027298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'MICROBIAL DELIVERY SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/843739 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26916 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027298.pdf [firstpage_image] =>[orig_patent_app_number] => 12843739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675007 [patent_doc_number] => 08383119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Biological substance nesfatin and its related substances and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/838760 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 41 [patent_no_of_words] => 55889 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12838760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8542876 [patent_doc_number] => 08318162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Antibodies to high molecular weight melanoma associated antigen' [patent_app_type] => utility [patent_app_number] => 13/384197 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21931 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6201952 [patent_doc_number] => 20110064738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'HUMAN ANTI-VEGF POLYCLONAL ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/822994 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9359 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064738.pdf [firstpage_image] =>[orig_patent_app_number] => 12822994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834706 [patent_doc_number] => 08450462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Compound' [patent_app_type] => utility [patent_app_number] => 12/821711 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 8674 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12821711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343648 [patent_doc_number] => 20100330115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody' [patent_app_type] => utility [patent_app_number] => 12/819618 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18690 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330115.pdf [firstpage_image] =>[orig_patent_app_number] => 12819618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601324 [patent_doc_number] => 20100322931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'ANTI-VEGF ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/817800 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 24912 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322931.pdf [firstpage_image] =>[orig_patent_app_number] => 12817800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504445 [patent_doc_number] => 20100260776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'THERAPEUTIC METHOD FOR REDUCING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/817676 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10907 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260776.pdf [firstpage_image] =>[orig_patent_app_number] => 12817676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8981586 [patent_doc_number] => 08512699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Anti-VEGF antibodies' [patent_app_type] => utility [patent_app_number] => 12/816188 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 50 [patent_no_of_words] => 54130 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12816188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582034 [patent_doc_number] => 20100291124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Extracellular serine protease' [patent_app_type] => utility [patent_app_number] => 12/802335 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10796 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291124.pdf [firstpage_image] =>[orig_patent_app_number] => 12802335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300990 [patent_doc_number] => 20120183547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'COMPOSITIONS AND METHODS COMPRISING VEGFR-2 AND VEGFR-3 ANTAGONISTS FOR THE TREATMENT OF METASTATIC DISEASE' [patent_app_type] => utility [patent_app_number] => 13/322447 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16249 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817444 [patent_doc_number] => 20120064064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'ANTIGEN-BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/322229 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18027 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064064.pdf [firstpage_image] =>[orig_patent_app_number] => 13322229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586373 [patent_doc_number] => 20110280883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'FULLY HUMAN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/781236 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4642 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280883.pdf [firstpage_image] =>[orig_patent_app_number] => 12781236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054572 [patent_doc_number] => 20110110932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'COMBINATION TREATMENT FOR OCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 12/768605 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10737 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110932.pdf [firstpage_image] =>[orig_patent_app_number] => 12768605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555106 [patent_doc_number] => 08067006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites' [patent_app_type] => utility [patent_app_number] => 12/766092 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16575 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067006.pdf [firstpage_image] =>[orig_patent_app_number] => 12766092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7976697 [patent_doc_number] => 08071095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Immunosuppressive polypeptides and nucleic acids' [patent_app_type] => utility [patent_app_number] => 12/763902 [patent_app_country] => US [patent_app_date] => 2010-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 132073 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071095.pdf [firstpage_image] =>[orig_patent_app_number] => 12763902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9345219 [patent_doc_number] => 08664368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Fully human monoclonal antibody to VEGF, preparation method and use thereof' [patent_app_type] => utility [patent_app_number] => 13/579218 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3074 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4460078 [patent_doc_number] => RE042324 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2011-05-03 [patent_title] => 'Compound for treatment of allergy and asthma' [patent_app_type] => reissue [patent_app_number] => 12/757821 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5525 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/042/RE042324.pdf [firstpage_image] =>[orig_patent_app_number] => 12757821 [rel_patent_id] =>[rel_patent_doc_number] =>)